부산대학교 도서관

Ying Huang; Nima S. Hejazi; Bryan Blette; Lindsay N. Carpp; David Benkeser; David C. Montefiori; Adrian B. McDermott; Youyi Fong; Holly E. Janes; Weiping Deng; Honghong Zhou; Christopher R. Houchens; Karen Martins; Lakshmi Jayashankar; Britta Flach; Bob C. Lin; Sarah O’Connell; Charlene McDanal; Amanda Eaton; Marcella Sarzotti-Kelsoe; Yiwen Lu; Chenchen Yu; Avi Kenny; Marco Carone; Chuong Huynh; Jacqueline Miller; Hana M. El Sahly; Lindsey R. Baden; Lisa A. Jackson; Thomas B. Campbell; Jesse Clark; Michele P. Andrasik; James G. Kublin; Lawrence Corey; Kathleen M. Neuzil; Rolando Pajon; Dean Follmann; Ruben O. Donis; Richard A. Koup; Peter B. Gilbert; on behalf of the Immune Assays; Moderna, Inc.; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE); United States Government (USG)/CoVPN Biostatistics Teams

Viruses, Vol 15, Iss 10, p 2029 (2023)

Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Hejazi NS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Blette B; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA 19104, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.; Montefiori DC; Department of Surgery, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.; McDermott AB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Deng W; Moderna, Inc., Cambridge, MA 02139, USA.; Zhou H; Moderna, Inc., Cambridge, MA 02139, USA.; Houchens CR; Biomedical Advanced Research and Development Authority, Washington, DC 20201, USA.; Martins K; Biomedical Advanced Research and Development Authority, Washington, DC 20201, USA.; Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC 20201, USA.; Flach B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Lin BC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; O'Connell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; McDanal C; Department of Surgery, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.; Eaton A; Department of Surgery, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.; Sarzotti-Kelsoe M; Department of Surgery, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.; Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Kenny A; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Carone M; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Huynh C; Biomedical Advanced Research and Development Authority, Washington, DC 20201, USA.; Miller J; Moderna, Inc., Cambridge, MA 02139, USA.; El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.; Baden LR; Brigham and Women's Hospital, Boston, MA 02115, USA.; Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA.; Campbell TB; Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Clark J; Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.; Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Pajon R; Moderna, Inc., Cambridge, MA 02139, USA.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Donis RO; Biomedical Advanced Research and Development Authority, Washington, DC 20201, USA.; Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; On Behalf Of The Immune Assays; Moderna Inc; Coronavirus Vaccine Prevention Network CoVPN/Coronavirus Efficacy Cove; United States Government Usg/CoVPN Biostatistics Teams

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE